Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Kishimoto, T.
Chawla, J. M.
Hagi, K.
Zarate, C. A.
Kane, J. M.
Bauer, M.
and
Correll, C. U.
2016.
Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories.
Psychological Medicine,
Vol. 46,
Issue. 7,
p.
1459.
Fawkner-Corbett, Joanna
and
Hall, Alison
2017.
A Worldwide Yearly Survey of New Data in Adverse Drug Reactions.
Vol. 39,
Issue. ,
p.
111.
Murrough, James W.
Abdallah, Chadi G.
and
Mathew, Sanjay J.
2017.
Targeting glutamate signalling in depression: progress and prospects.
Nature Reviews Drug Discovery,
Vol. 16,
Issue. 7,
p.
472.
Patel, Kinjal
Abdool, Petal S.
Rajji, Tarek K.
and
Mulsant, Benoit H.
2017.
Pharmacotherapy of major depression in late life: what is the role of new agents?.
Expert Opinion on Pharmacotherapy,
Vol. 18,
Issue. 6,
p.
599.
Balon, Richard
2017.
Clinical Factor 2016.
Psychotherapy and Psychosomatics,
Vol. 86,
Issue. 6,
p.
323.
Su, Tung-Ping
Chen, Mu-Hong
Li, Cheng-Ta
Lin, Wei-Chen
Hong, Chen-Jee
Gueorguieva, Ralitza
Tu, Pei-Chi
Bai, Ya-Mei
Cheng, Chih-Ming
and
Krystal, John H
2017.
Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression.
Neuropsychopharmacology,
Vol. 42,
Issue. 13,
p.
2482.
Lener, Marc S.
Kadriu, Bashkim
and
Zarate, Carlos A.
2017.
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.
Drugs,
Vol. 77,
Issue. 4,
p.
381.
Grunebaum, Michael F.
Galfalvy, Hanga C.
Choo, Tse-Hwei
Keilp, John G.
Moitra, Vivek K.
Parris, Michelle S.
Marver, Julia E.
Burke, Ainsley K.
Milak, Matthew S.
Sublette, M. Elizabeth
Oquendo, Maria A.
and
Mann, J. John
2018.
Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial.
American Journal of Psychiatry,
Vol. 175,
Issue. 4,
p.
327.
Zanos, Panos
Thompson, Scott M.
Duman, Ronald S.
Zarate, Carlos A.
and
Gould, Todd D.
2018.
Convergent Mechanisms Underlying Rapid Antidepressant Action.
CNS Drugs,
Vol. 32,
Issue. 3,
p.
197.
Short, Brooke
Fong, Joanna
Galvez, Veronica
Shelker, William
and
Loo, Colleen K
2018.
Side-effects associated with ketamine use in depression: a systematic review.
The Lancet Psychiatry,
Vol. 5,
Issue. 1,
p.
65.
Wilkinson, Samuel T.
Ostroff, Robert B.
Katz, Rachel B.
and
Krystal, John H.
2018.
Understanding Depression.
p.
223.
Zheng, Wei
Zhou, Yan-Ling
Liu, Wei-Jian
Wang, Cheng-Yu
Zhan, Yan-Ni
Li, Han-Qiu
Chen, Li-Jian
Li, Ming Ding
and
Ning, Yu-Ping
2018.
Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.
Journal of Psychiatric Research,
Vol. 106,
Issue. ,
p.
61.
Andrade, Chittaranjan
2018.
Ketamine as anaesthesia for ECT: is there room to improve a gold standard treatment?.
The British Journal of Psychiatry,
Vol. 212,
Issue. 3,
p.
129.
Gálvez, Verònica
Li, Adrienne
Huggins, Christina
Glue, Paul
Martin, Donel
Somogyi, Andrew A
Alonzo, Angelo
Rodgers, Anthony
Mitchell, Philip B
and
Loo, Colleen K
2018.
Repeated intranasal ketamine for treatment-resistant depression – the way to go? Results from a pilot randomised controlled trial.
Journal of Psychopharmacology,
Vol. 32,
Issue. 4,
p.
397.
Zhou, Yang
Peng, Yuming
Fang, Jinghan
Sun, Wanchen
Zhang, Guofu
Zhen, Long
Wang, Gang
and
Han, Ruquan
2018.
Effect of low-dose ketamine on PerioperAtive depreSsive Symptoms in patients undergoing Intracranial tumOr resectioN (PASSION): study protocol for a randomized controlled trial.
Trials,
Vol. 19,
Issue. 1,
Kim, Yong-Ku
and
Shin, Cheolmin
2018.
Rapid-Acting Antidepressant Effect of Ketamine and Its Clinical Application.
Journal of Korean Neuropsychiatric Association,
Vol. 57,
Issue. 2,
p.
108.
Wilkinson, Samuel T.
Ballard, Elizabeth D.
Bloch, Michael H.
Mathew, Sanjay J.
Murrough, James W.
Feder, Adriana
Sos, Peter
Wang, Gang
Zarate, Carlos A.
and
Sanacora, Gerard
2018.
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.
American Journal of Psychiatry,
Vol. 175,
Issue. 2,
p.
150.
Klise, Andrew
Lerner, Brian
Ettensohn, Marc F.
and
Levine, Steven P.
2018.
Ketamine Treatment for Mood Disorders.
Psychiatric Annals,
Vol. 48,
Issue. 4,
p.
175.
Sinyor, Mark
Williams, Marissa
Belo, Sue
Orser, Beverley
Vincent, Margaret
Mah, Linda
Zarate, Carlos
Castel, Saulo
Levitt, Anthony J.
and
Schaffer, Ayal
2018.
Ketamine augmentation for major depressive disorder and suicidal ideation: Preliminary experience in an inpatient psychiatry setting.
Journal of Affective Disorders,
Vol. 241,
Issue. ,
p.
103.
De Berardis, Domenico
Fornaro, Michele
Valchera, Alessandro
Cavuto, Marilde
Perna, Giampaolo
Di Nicola, Marco
Serafini, Gianluca
Carano, Alessandro
Pompili, Maurizio
Vellante, Federica
Orsolini, Laura
Fiengo, Annastasia
Ventriglio, Antonio
Yong-Ku, Kim
Martinotti, Giovanni
Di Giannantonio, Massimo
and
Tomasetti, Carmine
2018.
Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors.
International Journal of Molecular Sciences,
Vol. 19,
Issue. 10,
p.
2888.